Table 12PCOS: Comparison of 5-year responders to urinary, bowel, and sexual questions according to treatment* 75

DomainRP† (n=901)EBRT† (n=286)Odds ratio (95% CI)
Urinary
No control or frequent leaks vs. total control or occasional leaks14.4 (15.3)4.9 (4.1)4.4 (2.2–8.6)
Leaks ≥2 times per day‡15.6 (16.1)4.1 (3.6)5.3 (2.6–10.8)
Wears any pads to stay dry‡28.6 (28.6)4.2 (4.2)9.4 (4.7–18.9)
Frequent urination more than half the time‡10.6 (10.1)8.9 (9.3)1.1 (0.6–1.9)
Bothered by dripping or leaking urine§13.9 (14.3)3.0 (2.6)6.5 (2.7–15.6)
Bowel
Diarrhea‡23.3 (23.9)28.8 (26.7)0.84 (0.55–1.26)
Painful bowel movement‡10.4 (11.5)12.2 (9.4)1.31 (0.73–2.35)
Bowel urgency‡17.7 (19.3)33.4 (28.5)0.56 (0.36–0.87)
Wetness in rectal area‡13.8 (14.8)20.6 (18.3)0.75 (0.47–1.20)
Painful hemorrhoids‡11.0 (10.2)15.7 (19.6)0.43 (0.25–0.74)
Bothered by frequent bowel movement to pain or urgency4.3 (4.8)5.0 (4.0)1.23 (0.52–2.89)
Sexual
No/little interest in sexual activity46.5 (48.9)55.2 (47.4)1.1 (0.73–1.6)
No sexual activity48.9 (50.7)51.3 (43.9)1.4 (0.93–2.0)
Erection insufficient for intercourse‡76.9 (79.3)73.1 (63.5)2.5 (1.6–3.8)
Bothered by sexual dysfunction§47.4 (46.7)42.0 (44.6)1.1 (0.75–1.6)
*

EBRT is the referent group. Adjusted percentages are from separate logistic regression models, each adjusted for treatment propensity score, age, baseline function, race, comorbidity, and educational level. All estimates were weighted to total eligible cases.

RP = radical prostatectomy, EBRT = external beam radiotherapy. Values in columns are unadjusted percentages, in parentheses, adjusted percentages.

Percentages and odds ratios for yes vs. no/none.

§

For bother items, percentages refer to patients reporting a large or moderate problem vs. a small or no problem.

For the 5 bowel functions, percentages refer to patients reporting having the problem every day or some days vs. rarely or never.

From: 3, Results

Cover of Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer
Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer [Internet].
Comparative Effectiveness Reviews, No. 13.
Wilt TJ, Shamliyan T, Taylor B, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.